KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Revenue (2016 - 2025)

Historic Revenue for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $878.4 million.

  • Exact Sciences' Revenue rose 2312.19% to $878.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.2 billion, marking a year-over-year increase of 1769.29%. This contributed to the annual value of $3.2 billion for FY2025, which is 1769.29% up from last year.
  • As of Q4 2025, Exact Sciences' Revenue stood at $878.4 million, which was up 2312.19% from $850.7 million recorded in Q3 2025.
  • In the past 5 years, Exact Sciences' Revenue registered a high of $878.4 million during Q4 2025, and its lowest value of $402.1 million during Q1 2021.
  • In the last 5 years, Exact Sciences' Revenue had a median value of $625.2 million in 2023 and averaged $617.8 million.
  • Over the last 5 years, Exact Sciences' Revenue had its largest YoY gain of 6172.21% in 2021, and its largest YoY loss of 160.25% in 2021.
  • Quarter analysis of 5 years shows Exact Sciences' Revenue stood at $473.8 million in 2021, then grew by 16.71% to $553.0 million in 2022, then increased by 16.98% to $646.9 million in 2023, then increased by 10.29% to $713.4 million in 2024, then grew by 23.12% to $878.4 million in 2025.
  • Its last three reported values are $878.4 million in Q4 2025, $850.7 million for Q3 2025, and $811.1 million during Q2 2025.